The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Centessa Pharmaceuticals plc ADR’s stock clocked out at $13.03, up 2.84% from its previous closing price of $12.67. In other words, the price has increased by $2.84 from its previous closing price. On the day, 0.57 million shares were traded.
Ratios:
To gain a deeper understanding of CNTA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.25 and its Current Ratio is at 9.25. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on March 31, 2025, initiated with a Overweight rating and assigned the stock a target price of $38.
Morgan Stanley Upgraded its Equal-Weight to Overweight on September 20, 2024, whereas the target price for the stock was revised from $11 to $26.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 22 ’25 when SAHA SAURABH sold 40,344 shares for $12.43 per share. The transaction valued at 501,476 led to the insider holds 221,017 shares of the business.
SAHA SAURABH sold 14,656 shares of CNTA for $180,100 on Apr 21 ’25. The Chief Executive Officer now owns 261,361 shares after completing the transaction at $12.29 per share. On Apr 22 ’25, another insider, SAHA SAURABH, who serves as the Officer of the company, bought 40,344 shares for $12.43 each.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $19.09, while it has fallen to a 52-week low of $7.75. The 50-Day Moving Average of the stock is -12.57%, while the 200-Day Moving Average is calculated to be -12.70%.
Shares Statistics:
A total of 132.63M shares are outstanding, with a floating share count of 84.29M. Insiders hold about 36.45% of the company’s shares, while institutions hold 54.85% stake in the company.
